Elanco Animal Health Incorporated

ELAN

US28414H1032

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-07-07 pm EDT			5-day change	1st Jan Change
14.47 ^USD	-1.16%		+1.33%	+19.49%

Jul. 03	Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel	MT
Jul. 01	Neurizon Therapeutics Secures License Deal With Animal Health Company; Shares Up 3%	MT

Elanco Receives Positive Opinion On Zenrelia From EU's Committee

Published on 06/12/2025 at 16:20

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Elanco Animal Health Incorporated

Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel	Jul. 03	MT
Neurizon Therapeutics Secures License Deal With Animal Health Company; Shares Up 3%	Jul. 01	MT
Elanco Animal Health Incorporated Announces First Amendment Extends Receivables Loan Agreement Term to 2028	Jun. 26	CI
Elanco Animal Health Shares Rise After Upgrade From William Blair	Jun. 26	MT
William Blair Upgrades Elanco Animal Health to Outperform From Market Perform	Jun. 26	MT
Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency	Jun. 12	MT
Elanco Receives Positive Opinion On Zenrelia From EU's Committee	Jun. 12	RE
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products	Jun. 12	CI
Elanco Animal Health Incorporated Releases New Report Highlighting the Significance of America's Its Dogs and the Need for Itch Relief	Jun. 05	CI
Elanco Animal Health Incorporated Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 08:00 AM	May. 29
How Elanco Plans on Winning in the Pet Wellness Boom	May. 28	MT
Elanco Animal Health Incorporated Announces CFO Changes	May. 28	CI
Elanco Animal Health Incorporated Announces Change of Executive Vice President	May. 28	CI
Elanco Animal Health Incorporated Reconfirms Earnings Guidance for the Second Quarter and Full Year 2025	May. 28	CI
Elanco Animal Health Names Robert VanHimbergen CFO	May. 28	MT
Elanco Appoints Robert Vanhimbergen As Chief Financial Officer	May. 28	RE
Elanco Animal Health Incorporated Presents at BNP Paribas 2nd Annual Animal Health Day, May-22-2025 12:00 PM	May. 22
TD Cowen Adjusts Elanco Animal Health Price Target to $15 From $12, Maintains Buy Rating	May. 21	MT
Sector Update: Health Care Stocks Rise Late Afternoon	May. 07	MT
Elanco Animal Health Shares Rise After Q1 Beat	May. 07	MT
Elanco Animal Health Incorporated, Q1 2025 Earnings Call, May 07, 2025	May. 07
Elanco Animal Health's Q1 Adjusted Earnings Rise, Revenue Falls; Raises 2025 Revenue Guidance	May. 07	MT
Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 07	CI
Earnings Flash (ELAN) Elanco Animal Health Reports Q1 Revenue $1.19B, vs. FactSet Est of $1.17B	May. 07	MT
Earnings Flash (ELAN) Elanco Animal Health Posts Q1 Adjusted EPS $0.37, vs. FactSet Est of $0.31	May. 07	MT

Chart Elanco Animal Health Incorporated

Duration

Period

ELAN: Dynamic Chart

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.

Employees

9,225

Sector

Pharmaceuticals

Calendar

Aug. 10 - Q2 2025 Earnings Release (Projected)

More about the company